Rick Zall is a partner and chair of King & Spalding’s healthcare transactional and regulatory practice. He represents clients on both transactional and regulatory healthcare matters, including advising healthcare operating companies, private equity investors and lenders on M&A, joint ventures, financings and complex commercial transactions. He advises on state and federal healthcare regulatory compliance matters, including navigating fraud and abuse and corporate practice of medicine prohibitions, Medicare and Medicaid payment rules. Rick also counsels clients in the emerging digital health and health information technology sectors on compliance with data privacy and security laws, telemedicine licensure regulations and health benefit management.
With deep experience in the healthcare industry, Rick is known for practical and effective solutions to successfully structure, negotiate and close deals for his clients.
Rick advises clients on regulatory compliance matters including fraud and abuse, corporate practice of medicine, structuring physician incentive arrangements, digital health/telemedicine, HIPAA, Medicare/Medicaid reimbursement and value-based payments.
Prior to joining King & Spalding, Rick was a partner and the chairman of the healthcare practice for an Am Law 100 firm.